A Study of TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies

NCT02000934 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor and Lymphoma Malignancies

Interventions

DRUG: TAK-659

Sponsor

Calithera Biosciences, Inc